Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

Atherosclerosis is the leading cause of global morbidity and mortality. Its therapy requires research in several areas, such as diagnosis of early arteriosclerosis, improvement of the pharmacokinetics and bioavailability of rapamycin as its therapeutic agents. Here, we used the targeting peptide VHP...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chen, Huang, Wentao, Zhang, Lifen, Zhang, Chunyu, Zhou, Chengqian, Wei, Wei, Li, Yongsheng, Zhou, Quan, Chen, Wenli, Tang, Yukuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146689/
https://www.ncbi.nlm.nih.gov/pubmed/35631669
http://dx.doi.org/10.3390/pharmaceutics14051083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146689/
https://www.ncbi.nlm.nih.gov/pubmed/35631669
http://dx.doi.org/10.3390/pharmaceutics14051083

Ejemplares similares